Combined 18F-fluorodeoxyglucose positron emission tomography and event-related potentials study of the cognitive impairment mechanisms in Parkinson’s disease

•P300 decrease in NoGo condition was found in PD patients with cognitive impairment.•Cerebral glucose metabolism rate was correlated with ERP amplitude.•Executive dysfunction plays the crucial role in cognitive impairment in PD. This study aimed to analyze positron emission tomography with 18F-fluor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical neuroscience 2020-02, Vol.72, p.335-341
Hauptverfasser: Khomenko, I.G., Pronina, M.V., Kataeva, G.V., Kropotov, J.D., Irishina, Y.A., Susin, D.S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•P300 decrease in NoGo condition was found in PD patients with cognitive impairment.•Cerebral glucose metabolism rate was correlated with ERP amplitude.•Executive dysfunction plays the crucial role in cognitive impairment in PD. This study aimed to analyze positron emission tomography with 18F-fluorodeoxyglucose data and event-related potentials in the Go/NoGo paradigm in patients with Parkinson’s disease with and without cognitive impairment. In the group of cognitively impaired patients, glucose metabolism was decreased in the frontal, parietal, cingulate and posterior temporal cortex. Correlations were found between the cognitive scores and cerebral glucose metabolism in those areas. Event-related potentials analysis revealed a decrease in the amplitude of the late positive wave (P300 NoGo wave) in the group of cognitively impaired patients. The analysis revealed that decline in amplitude of P300 wave was accompanied by decreased glucose metabolism in several cortical areas associated with cognitive impairment in Parkinson’s disease. Correlations of glucose metabolism in these areas with event-related potentials amplitude in the NoGo condition confirm the important role of executive functions disorders in the pathogenesis of cognitive impairment in Parkinson’s disease.
ISSN:0967-5868
1532-2653
DOI:10.1016/j.jocn.2019.11.044